Aspirin for Treatment of Multiple Sclerosis-Related Fatigue

This study has been terminated.
(Slow accrual, and interim analysis indicated the treatment was less effective than planned.)
Sponsor:
Collaborator:
National Multiple Sclerosis Society
Information provided by (Responsible Party):
Dean Wingerchuk, Mayo Clinic
ClinicalTrials.gov Identifier:
NCT00467584
First received: April 26, 2007
Last updated: January 17, 2014
Last verified: January 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: September 2013
  Primary Completion Date: September 2013 (Final data collection date for primary outcome measure)